NYC H+H/Bellevue — New York, New York

NYC H+H/Bellevue is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

NYC H+H/Bellevue has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Deafness, VEXAS Syndome, Autoinflammatory Disease.

Sponsors: NYU Langone Health.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYC H+H/Bellevue?

NYC H+H/Bellevue has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYC H+H/Bellevue conducted?

NYC H+H/Bellevue has 3 clinical trials on record, with 3 currently active. Their work covers Deafness, VEXAS Syndome, Autoinflammatory Disease.

Is NYC H+H/Bellevue accredited by Crixeo Health?

NYC H+H/Bellevue has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYC H+H/Bellevue?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.